# AI_MODEL_PERFORMANCE_MONITORING.md  
**Continuous AI Model Performance Monitoring Framework**

---

## 1. Purpose

This document defines the mandatory framework for **continuous monitoring of AI model performance** within the NeuroGrid ecosystem.

Its objectives are to:
- Detect performance degradation early
- Prevent silent model failure
- Maintain clinical safety and reliability
- Ensure regulatory compliance
- Support evidence-based governance decisions

AI systems must remain **observable, measurable, and accountable** throughout their lifecycle.

---

## 2. Scope

This framework applies to:
- All deployed AI models
- Clinical decision support models
- RPM and post-operative monitoring systems
- Predictive, classification, and anomaly-detection models
- Models operating in live or shadow mode

Monitoring obligations begin **at first deployment** and persist until model retirement.

---

## 3. Core Principle

> **No AI model may operate in production without active performance monitoring.**

Undetected degradation constitutes a system failure.

---

## 4. Performance Dimensions

Model performance is evaluated across **five mandatory dimensions**:

| Dimension | Description |
|--------|-------------|
| Accuracy | Correctness of predictions |
| Reliability | Consistency across time and populations |
| Robustness | Stability under noisy or missing data |
| Safety | Absence of harmful outputs |
| Fairness | Performance parity across subgroups |

All dimensions must be monitored continuously.

---

## 5. Key Performance Metrics

Depending on model type, required metrics include:

- Sensitivity / Recall  
- Specificity  
- Precision  
- False Positive Rate  
- False Negative Rate  
- AUROC / AUPRC  
- Calibration error  
- Confidence-accuracy alignment

Metrics must be predefined prior to deployment.

---

## 6. Baseline Establishment

Before deployment:
- A validated baseline must be established
- Baseline data must reflect intended clinical context
- Acceptable variance thresholds must be documented

Baselines are immutable once approved.

---

## 7. Monitoring Frequency

| Model Criticality | Monitoring Interval |
|------------------|---------------------|
| High-risk clinical | Real-time / Daily |
| Moderate risk | Weekly |
| Low risk / research | Monthly |

High-risk systems must support near-real-time monitoring.

---

## 8. Performance Degradation Thresholds

Thresholds must be defined for:
- Metric decline
- Confidence misalignment
- Error rate spikes
- Subgroup divergence

Crossing a threshold triggers:
- Automated alerts
- Governance review
- Possible model restriction

---

## 9. Alerting & Escalation

Performance alerts must:
- Be automated
- Be logged immutably
- Include metric context
- Trigger predefined response workflows

Escalation paths must align with:
- Clinical risk level
- Regulatory obligations
- DAO governance rules

---

## 10. Human Oversight

Performance monitoring is:
- Reviewed by qualified personnel
- Interpreted with clinical context
- Not solely automated

Human oversight is mandatory at all escalation levels.

---

## 11. Audit Logging

The following must be logged:
- Metric values over time
- Threshold crossings
- Human review decisions
- Model interventions

Logs must be:
- Tamper-resistant
- Time-stamped
- Retained per regulatory requirements

---

## 12. Performance Review Cycles

Formal performance reviews must occur:
- After deployment
- After major data shifts
- After incident reports
- On a scheduled cadence

Reviews produce documented findings and action items.

---

## 13. Governance Enforcement

DAO governance enforces:
- Monitoring compliance
- Performance transparency
- Threshold validation
- Intervention authorization

Failure to monitor performance may result in:
- Model suspension
- Deployment rollback
- Governance sanctions

---

## 14. Regulatory Alignment

This framework aligns with:
- FDA GMLP performance monitoring guidance
- EU AI Act post-market monitoring
- ISO/IEC 23894 AI risk management
- IEC 62304 post-deployment controls
- ANVISA and SAHPRA post-market expectations

---

## 15. Ethical Position

> **An AI model that cannot be measured cannot be trusted.**

Continuous monitoring is a moral obligation, not a technical feature.

---

## 16. Binding Status

This document is:
- Mandatory for all NeuroGrid models
- Enforced via governance mechanisms
- Audited continuously
- Modifiable only through DAO-approved change control

---

### Status
**Active – AI Model Performance Monitoring Framework**

